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A step-by-step guide to implementing
a multidisciplinary endocarditis team
Sami El-Dalati , Daniel Cronin, James Riddell IV, Michael Shea, Richard L. Weinberg,
Emily Stoneman, Twisha Patel, Kirra Ressler and George Michael Deeb

Abstract: Over the last several years multiple studies, primarily from European centers have
demonstrated the clinical and outcomes benefits of multidisciplinary endocarditis teams.
Despite this literature, adoption of this approach to patient care has been slower in the United
States. While there is literature outlining the optimal composition of an endocarditis team,
there is little information to guide providers as they attempt to transform practice from a
fragmented, disjointed process to an efficient, collaborative care model. In this review, the
authors will outline the steps they took to create and implement a successful multidisciplinary
endocarditis team at the University of Michigan. In conjunction with existing data, this
piece can be used as a resource for clinicians seeking to improve the care of patients with
endocarditis at their institutions.
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Introduction
Over the last several years, there has been an
increasing interest in the clinical implementation
of multidisciplinary endocarditis teams.1 Since
the first publication in 2009 demonstrating the
mortality benefits associated with such groups,
they have become the standard of care for the
diagnosis and management of endocarditis at
European tertiary care medical centers.2,3
Adoption of this coordinated approach has been
slower in North America, although one recent
study from the University of Michigan demonstrated a dramatic reduction in in-hospital endocarditis mortality after the implementation of a
multidisciplinary endocarditis team.4 In addition,
the increase in endocarditis associated with the
opioid epidemic has sparked interest in developing a similar model of care in the United States.5,6
Several publications have discussed the basic
organization and structure of such groups. These
papers have included direction regarding which
specialists should be involved, how referrals from
transferring hospitals should be coordinated and
the role of the team in participating in clinical
research.1,7 However, there has been little

discussion about the logistics behind how a large
institution transforms its endocarditis practice
from a fragmented, disjointed process to an efficient, collaborative care model. Moreover, the
majority of previous publications on this topic
have come from European centers. While there
are undoubtedly many areas of overlap, the
American and European systems of health care
have substantial differences that impact the effective development of these groups. In this piece,
the authors will discuss the step-by-step approach
they took to creating a successful multidisciplinary endocarditis team at the University of
Michigan (Figure 1).4
Phase I: identify the clinical leader(s)
One of the most important components of this
process is identifying who will coordinate and
lead a newly formed multidisciplinary endocarditis team. Having designated leadership is crucial
for recruitment of team members, reviewing
existing outcomes (see Phase II), organizing and
moderating meetings and directing research. It is
also helpful to have a ‘point person’ for other
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Figure 1. Graphic overview of the authors’ step-by-step approach to developing a multidisciplinary
endocarditis team.

providers and administrators at an institution to
contact with questions about endocarditis. The
leadership can also apply for institutional review
board (IRB) approval for review of retrospective
data and future team research projects. Depending
on the hospital, there may be funding available
for such a position. However, in practice these,
efforts often develop without financial support.
Ideally, the multidisciplinary team will be led by
1–2 individuals who are principally involved in
the care of patients with endocarditis at the institution. Infectious disease (ID) providers are well
suited for this role as every patient with endocarditis requires antibiotic therapy, and ID consultation has been shown to improve mortality in
multiple types of blood stream infections.8,9
However, cardiac surgeons, cardiologists and
hospitalists are also good candidates for this position. In some circumstances, medical residents or
fellows can play a significant role as they are wellversed in hospital workflow and may have protected research time they can devote to the
project.10 If the development of an endocarditis
team is driven by the hospital administration,
then the team leadership may be appointed. In
the absence of such a directive, then the clinical
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leads are often the individuals who are most passionate about improving the care of the patients
with endocarditis or have clinical or research
interests in this domain.
Phase II: identify the problem(s)
A crucial early step is understanding the population of patients with endocarditis that an individual institution cares for and what their clinical
outcomes are relative to national numbers. In the
United States, the in-hospital mortality for infectious endocarditis is reported as ranging from
15% to 20%, but theses outcomes may vary
between regions and medical centers.11 Utilizing
an internal data collection tool, the authors performed a retrospective chart review of all endocarditis admissions to their institution over a
1-year period in order to help better understand
the patient population and its needs.4 A developing endocarditis team should understand its own
institution’s mortality outcomes and attempt to
identify which variables contribute to these
results. For example, it is important to determine
whether a significant proportion of the hospital’s
patients with endocarditis are individuals who
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Figure 2. Fishbone diagram created by members of the University of Michigan Multidisciplinary Endocarditis
Team outlining potential factors contributing to increased mortality for patients with endocarditis.

inject drugs. This will help inform the future
composition of the team as addiction medicine/
psychiatry and social work play critical roles in
caring for this population.12 If these providers are
not already available at an institution, endocarditis team members can advocate for their hospital
to acquire more addiction treatment resources.
There are myriad challenges associated with caring for all patients with endocarditis with many
opportunities for interruptions in care. During
preliminary meetings, the authors used a quality
improvement informed approach to create a ‘fishbone diagram’ that identified factors contributing
to delays in care or adverse outcomes (Figure 2).13
As highlighted in Figure 2, delays may occur in
obtaining certain diagnostic testing, such as
transesophageal echocardiography, magnetic resonance imaging, or coronary angiography.14 At
the authors institution most patients with endocarditis are admitted as outside hospital referrals
for surgical evaluation. However, many of these
transfers happen on Friday evenings due to bed
availability. Endocarditis admissions occurring
over the weekend have notably been associated
with adverse outcomes.15 Consequently, the
authors’ endocarditis team scheduled meetings
on Monday mornings to ensure that all patients
presenting over the weekends were discussed by
journals.sagepub.com/home/tai

the group in a timely fashion. In addition, medical providers may not always be aware of endocarditis surgical indications or may feel that
patients are unlikely to be offered surgery. This
may result in delays in or the absence of cardiac
surgical consultation which can in-turn serve to
increase in-hospital mortality as early surgical
intervention is associated with improved clinical
outcomes.16–18 At our institution, these obstacles
were overcome by hiring an advanced practice
provider (APP) to increase the capacity of the cardiac surgery department to see new consults and
by development of a best practice advisory in the
electronic medical record that suggested a cardiac
surgery consultation to providers whenever a
diagnosis of endocarditis was made.
Phase III: recruiting team members
After a leadership structure has been identified
and existing outcomes are reviewed, the next
phase involves recruitment of the other key team
members. Previous studies have highlighted that
an effective multidisciplinary endocarditis team
should include representatives from ID, cardiac
surgery, cardiology (including cardiologists with
expertise in echocardiography and electrophysiology), neurology and/or neurosurgery, and pharmacy (Table 1).1,2 Inclusion of addiction medicine/
3
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Table 1. Roles and recommended attendance of the specialties comprising a multidisciplinary endocarditis team.
Specialty

Role

Recommended attendance

Infectious diseases

1.
2.
3.
4.

Case ascertainment
Screen patients for substance use disorder
Selection of antibiotic regimen and duration
Coordinate outpatient follow-up

All meetings

Cardiology

1. Review echocardiographic and angiographic
imaging
2. Provide recommendations for and interpretation
of advanced cardiac imaging modalities (i.e., PET)
3. Recommendations regarding follow-up imaging

All meetings

Cardiac Surgery

1. Evaluate and select patients for valve surgery
2. Recommendations regarding pre-operative
testing
3. Recommendations regarding follow-up

All meetings

Pharmacy

1. Recommendations about optimal dosing of
antimicrobial

All meetings

Neurology

1. Recommendations about neurologic imaging
As needed – for patients with known
2. Recommendations about the timing of antineurologic complications of endocarditis
coagulation in patients undergoing valve surgery

Neurosurgery

1. Screening and management of mycotic
aneurysms

Addiction medicine/psychiatry

1. Initiation of medication assisted treatment for
As needed – for patients with substance
substance use disorder
use disorder complicating the diagnosis of
2. Link patients to outpatient programs for ongoing endocarditis
treatment

As needed – for patients with known
neurologic complications of endocarditis

PET, positron-emission tomography.

psychiatry and social work is also imperative as
almost all referral centers will care for patients
with injection drug use associated endocarditis.12
If the hospital has an outpatient antimicrobial
treatment program, it may be beneficial to include
these providers as well. Although not every patient
with endocarditis will have an indication for valve
surgery initially, they may develop indications
subsequently. In addition, cardiac surgeons provide valuable experience and perspective when
considering complex valvular pathology as evidenced by their inclusion in heart valve teams.19
Neurology and neurosurgery participation could
be limited to instances when patients have a neurologic complication of endocarditis.
The identification of team members may be challenging, given that in most circumstances, there is
no financial reimbursement to providers for the
time commitment associated with participation.
There can be multiple effective strategies for

4

recruiting providers from the various necessary
specialties. If the endocarditis team leader(s) are
well known in the hospital, then direct communication with a colleague is a straightforward and
expedient approach. However, if the leadership is
relatively new to the medical center, then it may
be prudent to have these individuals present the
existing endocarditis data and the benefits of multidisciplinary endocarditis teams to the various
specialties at a regularly scheduled departmental
meeting. The authors both directly contacted
providers with whom they had existing relationships and presented at the monthly faculty meetings for the divisions of cardiology, infectious
diseases, and the department of cardiac surgery.
If possible, teams should seek to involve 2–3 specialists from each department to ensure that consistent representation is not dependent on the
availability of one person. The authors would also
recommend including any APPs that work closely
with physicians in the designated specialties.

journals.sagepub.com/home/tai
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Phase IV: scheduling the meetings/choosing
a location
Scheduling a meeting may seem like a mundane,
straightforward task that should not require much
discussion. However, an effective endocarditis
team is comprised of upwards of 10 medical providers who have numerous competing clinical and
research responsibilities. While all providers are
important to the success of the team, cardiac surgery is the most specialized of the involved disciplines and is closely associated with improved
endocarditis survival.16–18 In addition, surgeons
often have limited availability for such interdisciplinary work, given their responsibilities in the operating room. Therefore, the authors would recommend
scheduling the meetings to accommodate as many
cardiac surgeons as possible. This will require other
team members to also acknowledge the prominent
role of cardiac surgery. The day(s) of the week the
meeting is held can also have significant impact on
the team’s effectiveness. As alluded to previously,
at the authors institution many patients are admitted over the weekend, prompting the scheduling of
one team meeting on Monday mornings. The
authors would recommend against holding conferences on Fridays as it may be challenging for team
recommendations to be implemented prior to and
over the weekend. Depending on the clinical volume some hospitals may find it necessary to meet
for 30 or 60 minutes and to hold more than 1 meeting per week. Ad hoc meetings can be considered
but may be hard to implement, given the busy practices of the involved clinicians. One advantage of
the multidisciplinary endocarditis team is that it
fosters familiarity between providers which can
allow for increased communication regarding
patient care outside of scheduled meetings, such as
via phone call or e-mail.
With respect to choosing a designated meeting
place, again it may be practical to select a location
in close proximity to the surgery departmental
offices. The ideal space has the capacity to seat
15–20 people with audio-visual capabilities,
including access to echocardiographic and coronary angiographic images so that they may be
reviewed by team specialists. Ultimately, the
authors elected to hold their meeting in the cardiac surgery conference room adjacent to the surgeons’ offices. Generally, the authors recommend
that the endocarditis team meet in-person to
allow providers to build rapport with one another
and to avoid miscommunications or interpersonal
conflict. However, providing a virtual meeting
journals.sagepub.com/home/tai

option may also allow for increased attendance
and social distancing if necessary.
Phase V: developing a protocol
Once the key team members have been selected
and a designated meeting time and location are
chosen, initial discussions would ideally focus on
developing an institutional protocol for management of endocarditis cases. Although there are
consensus endocarditis management guidelines
published by the American Heart Association and
the European Society of Cardiology (ESC), there
are also notable gaps in these resources.3,20
Among these are issues surrounding the management of patients with injection drug use associated endocarditis. In addition, the broader
medical endocarditis literature is limited by a
dearth of randomized controlled trial in this
patient population. Consequently, there is significant provider-dependent variability with respect
to management recommendations, particularly
surrounding decisions regarding echocardiographic imaging, surgery, and neurologic complications of endocarditis. Such protocols have
correlated with the improvement in clinical outcomes described in previous studies.2 While there
are some aspects of endocarditis patient care that
are consistent among hospitals, each institution
has its own unique patient population as well as
strengths and weaknesses. For example, positronemission tomography (PET) is endorsed by the
ESC guideline as an important adjunctive tool for
diagnosing endocarditis.3 However, many centers
do not have clinical cardiac PET programs available to them. The multidisciplinary endocarditis
team, supported by internal data (see Phase II), is
best equipped to tailor a protocol unique to their
hospital. After creation of their endocarditis team,
the authors spent the first month of their group’s
meetings developing a protocol which provided
guidance about initial laboratory and imaging
evaluation in suspected endocarditis, when to
pursue advanced cardiac imaging modalities, how
to screen for substance use disorders and when to
involve addiction treatment providers, recommendations about neurologic imaging and when
to pursue medical or surgical management. The
authors’ full protocol has been previously published elsewhere.4 Once a consensus document is
created and approved by team members, the
authors would recommend that the group makes
the algorithm publicly available to all health care
providers within their institution.
5
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Phase VI: case identification
In general, all cases of definite endocarditis as
defined by the modified Duke Criteria should be
presented for discussion by the multidisciplinary
endocarditis team.21 The authors would also suggest that the group present patients with possible
endocarditis, particularly if a valve vegetation is
present, given the relative insensitivity of the
Duke Criteria.22 It is also reasonable for the team
to consider cases where the diagnosis is uncertain
at the request of the patient’s primary medical
providers. The process of ascertaining endocarditis cases for presentation at regular gatherings of
the endocarditis team may vary considerably
between hospitals. Team leaders can consider different approaches based on their center’s internal
workflow. Methods for identifying patients can
include utilizing the ID consult service (the
authors’ approach) as the majority of, if not all,
patients with endocarditis will receive ID consultation. Depending on the volume of patients, the
ID division may consider dedicating one of their
consult services specifically to patients with endocarditis. The cardiac surgery consult team may
also capture patients who are not identified by
ID. Alternatively, patients can be found using
ICD diagnosis codes. However, this approach
may result in detection of an excess number of
patients including those with a history of endocarditis that is not relevant to their current presentation. If this strategy is selected, the
endocarditis team would then have to review each
case to ensure they are appropriate for discussion.
A formalized referral process could be considered
but would require the presence of individuals who
can review and triage patient cases.
Phase VII: conducting the meetings/case
presentations
After recruiting members, agreeing to a standardized protocol and determining a method of case
identification, the team is now positioned to begin
presenting patient cases. There is no literature to
support the best method for how to review
patients. However, the authors have found from
personal experience that certain practices may
improve the caliber of the team’s discussion and
the effectiveness of the meetings. First, the team
leads should contact the group with a list of
patients to be presented approximately 24 hours
before the meeting. This will allow team members who are not directly involved in a patient’s
care to review the case details in advance. For
6

example, a neurologist can review patient imaging
and provide recommendations via email about
timing of anti-coagulation prior to the meeting.
The authors also recommend that the endocarditis team invite providers from patients’ primary
teams to the conferences as well as any consultants that may not be team members but whose
input will directly impact management (for example, including a hepatologist for a patient with cirrhosis). It may be helpful to have a designated
physician or APP moderator who facilitates the
conversation and calls on specialists to give their
input on pertinent clinical questions. This individual can also prepare a brief visual presentation
that includes background on the patient’s medical, surgical and social history as well as the results
of validated surgical and embolism risk calculators.23,24 This presentation would ideally also
include pertinent radiologic, echocardiographic,
and angiographic images. After hearing input
from team members, the moderator can then help
summarize the discussion and push the group
toward making a final recommendation. The
team can also use its meetings as an internal morbidity and mortality conference to review adverse
events or poor outcomes, thereby continuing process improvements on a regular basis.
Phase VIII: documenting and
communicating recommendations
A critical component of a successful endocarditis
team is efficient and clear documentation of recommendations. Although providers cannot bill
for their involvement with these meetings, the
communication of recommendations through the
medical record allows providers who are unable
to attend the meetings to reference the discussion. Documentation is ideally completed by one
of the team leads or the meeting moderator. A
previous survey of providers at the authors’ institution found that a majority of health care providers felt the implementation of a multidisciplinary
endocarditis team led to improved documentation of clinical recommendations.25 Since the
note is not being utilized for billing purposes, it
can focus explicitly on the medical decision-making. For future research purposes, it may be useful for the team to document in their note
important features of the case including the Duke
Criteria, type and location of the involved valve,
etiologic organism, echocardiographic and radiologic findings as well as surgical and embolism
risk calculations. Ideally, primary team members
journals.sagepub.com/home/tai
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will attend the multidisciplinary discussion.
However, if they are unable due to their other
clinical responsibilities the authors suggest that
an endocarditis team member convey the recommendations either in-person or by phone.
Phase IX: maintaining a
database/applying for funding
In order to demonstrate its clinical benefit, the
multidisciplinary endocarditis team should longitudinally follow their patients with an institutional
registry. As discussed earlier, the team leadership
can apply for IRB approval to store patient information and review mortality. Collection of a
broad range of demographic, clinical, microbiologic, echocardiographic, and outcome-related
variables will help the team understand how it is
affecting patient care and creates substantial
research opportunities.4 Although dedicated
funding to support an endocarditis team may not
be initially available, if the group can demonstrate
decreases in mortality, length of stay, readmissions, or antibiotic usage then they can petition
their hospital for financial support as a cost-saving measure. Assessment of clinicians’ perceptions of the endocarditis team can also help guide
future team decisions. A survey of providers at
the authors’ institution demonstrated that over
85% of respondents agreed that the group influenced diagnostic evaluation, reduced management errors, increased access to surgery, and
decreased in-hospital mortality for patients with
endocarditis.25 In addition, once the team has
collected sufficient data it can apply for external
research grant funding. With dedicated resources
the multidisciplinary endocarditis team could
expand its reach, by offering virtual consultation
to providers at smaller hospitals within a given
healthcare network, as recommend by the ESC
guidelines.3
Conclusion
While the clinical benefits of multidisciplinary
endocarditis teams are well-established, creation
of an effective, consistent collaboration between
multiple specialties can be challenging to
accomplish. There are numerous variables to consider, any of which can derail this promising initiative. Despite the inclusion of endocarditis teams in
the ESC guidelines, there has been little direction
provided to clinicians about how to best construct
and operate these groups. In this paper, the
journals.sagepub.com/home/tai

authors have used their own data-supported personal experiences as well as available data to outline a step-by-step guide to creation of a successful
multidisciplinary endocarditis team. In conjunction with existing literature, this piece can be used
as a resource for clinicians seeking to improve the
care of patients with endocarditis at their
institutions.
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